Clinical Trials Logo

Clinical Trial Summary

Orbital masses develop at the expense of the orbital structures lacrimal glands, oculomotor muscles, optic nerve, meningeal spaces, peripheral nerves, bone wall, orbital fat, lymphoid structures or vascular structures. These masses can be tumors, benign or malignant, or pseudotumor, mainly represented by specific or non-specific orbital inflammation. Pathology is of considerable importance for the diagnosis and the treatment of those masses. However, biopsy or surgical resection of the orbital masses is sometimes difficult and dangerous outside expert centers. The identification of a non-invasive technique for distinguishing tumors from pseudotumors, thus avoid in some cases a biopsy, would be a major contribution for the patients. For salivary glands, MRI allows to identify 4 different types of MRI characteristics, one (type C) being related to malignant tumors. In this study, the investigators will try to see if extrapolation of those data to orbiltal tumors is feasible.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02434120
Study type Observational
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact
Status Completed
Phase
Start date November 2015
Completion date August 8, 2022

See also
  Status Clinical Trial Phase
Completed NCT02401906 - MRI and Orbital Tumours (MEDORT)
Completed NCT05613244 - Descriptive Study of a Cohort of Orbital Solitary Fibrous Tumors
Recruiting NCT04704414 - Exophthalmometry With 3D Face Scanners N/A